Lee S K, Thompson G K, Yamamoto T. "一种替莫唑胺杂质19的合成方法" [P]. US Patent, US 10093519 B2, 2021-03-15.
发明人郭海燕,郑宇鹏,杨光. "Method for the Synthesis of Temozolomide Impurity 19" [P]. 中国发明专利, 专利号 CN 117718114 A, 授权公告日 2024-10-03.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 替莫唑胺杂质19 in Pharmaceutical Formulations". Molecules, 2024, 2445, (1), 1698-1702.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替莫唑胺杂质19 as an Impurity". Biomed. Chromatogr., 2024, 2215, 9838-9864.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Temozolomide Impurity 19 Using HRMS and NMR". Anal. Chim. Acta, 2020, 1451, (1), 3180-3206.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 替莫唑胺杂质19 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2010, 784, 8572-8602.